CLINICAL STAGE: STAGE II (T3-4, N-)

Clinical trials for CLINICAL STAGE: STAGE II (T3-4, N-) explained in plain language.

Never miss a new study

Get alerted when new CLINICAL STAGE: STAGE II (T3-4, N-) trials appear

Sign up with your email to follow new studies for CLINICAL STAGE: STAGE II (T3-4, N-), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New immunotherapy approach targets advanced cancers before surgery

Disease control Recruiting now

This study is testing whether adding an immunotherapy drug called TSR-042 before standard chemoradiation and surgery works better for advanced solid tumors with specific genetic features. Researchers want to see if this combination helps eliminate cancer cells more effectively. T…

Matched conditions: CLINICAL STAGE: STAGE II (T3-4, N-)

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

CLINICAL STAGE: STAGE II (T3-4, N-)

Get alerted when new CLINICAL STAGE: STAGE II (T3-4, N-) trials appear

New immunotherapy approach targets advanced cancers before surgery